HONG KONG AND THE INDO-CHINESE REFUGEES: REF1ECTIONS ON THE INTERNATIONAL REFUGEE ENVIRONMENT




Overall survival benefits for combining targeted therapy as second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of published data.

BACKGROUND: Combining targeted therapy has been extensively investigated in previously treated advanced non-small-cell lung cancer (NSCLC), but it is still unclear whether combining targeted therapy might offer any benefits against standard monotherapy with erlotinib.We thus performed a meta-analysis of randomized controlled trials to compare the e

read more